From Wikipedia, the free encyclopedia
Nadoxolol
|
Names
|
IUPAC name
N′,3-Dihydroxy-4-naphthalen-1-yloxybutanimidamide
|
Identifiers
|
|
|
|
|
ChemSpider
|
|
EC Number
|
|
MeSH
|
C006154
|
|
|
UNII
|
|
|
|
InChI=1S/C14H16N2O3/c15-14(16-18)8-11(17)9-19-13-7-3-5-10-4-1-2-6-12(10)13/h1-7,11,17-18H,8-9H2,(H2,15,16) Key: UPZVYDSBLFNMLK-UHFFFAOYSA-N InChI=1/C14H16N2O3/c15-14(16-18)8-11(17)9-19-13-7-3-5-10-4-1-2-6-12(10)13/h1-7,11,17-18H,8-9H2,(H2,15,16) Key: UPZVYDSBLFNMLK-UHFFFAOYAW
|
C1=CC=C2C(=C1)C=CC=C2OCC(C/C(=N/O)/N)O
|
Properties
|
|
C14H16N2O3
|
Molar mass
|
260.293 g·mol−1
|
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
Chemical compound
Nadoxolol is an
antiarrhythmic agent (i.e., a drug for the treatment of irregular heartbeat),
[1] chemically related in structure to
beta-adrenergic receptor blocker drugs such as
propranolol.
[2]
It does not appear to be marketed anywhere in the world.
References
-
^ Warembourg, H; Ducloux, G (1976). "Clinical study of a new anti-arrhythmia agent: nadoxolol". Lille Med. 21 (4): 386–8.
PMID
957857.
-
^ Kapoor, M; Anand, N; Koul, S; Chimni, SS; Manhas, KS; Raina, C; Parshad, R; Taneja, SC; Qazi, GN (2003). "Kinetic resolution of 1-chloro-3-(1-naphthyloxy)-2-propanol, an intermediate in the synthesis of beta-adrenergic receptor blockers". Bioorganic Chemistry. 31 (3): 259–69.
doi:
10.1016/s0045-2068(03)00050-6.
PMID
12818235.
|
---|
α1 | Agonists | |
---|
Antagonists |
-
Abanoquil
-
Ajmalicine
-
Alfuzosin
-
Anisodamine
-
Anisodine
-
Atiprosin
-
Atypical antipsychotics (e.g.,
brexpiprazole,
clozapine,
olanzapine,
quetiapine,
risperidone)
-
Benoxathian
-
Beta blockers (e.g.,
adimolol,
amosulalol,
arotinolol,
carvedilol,
eugenodilol,
labetalol)
-
Buflomedil
-
Bunazosin
-
Corynanthine
-
Dapiprazole
-
Domesticine
-
Doxazosin
-
Ergolines (e.g.,
acetergamine,
ergotamine,
dihydroergotamine,
lisuride,
nicergoline,
terguride)
-
Etoperidone
-
Fenspiride
-
Hydroxyzine
-
Indoramin
-
Ketanserin
-
L-765,314
-
mCPP
-
Mepiprazole
-
Metazosin
-
Monatepil
-
Moxisylyte
-
Naftopidil
-
Nantenine
-
Neldazosin
-
Niaprazine
-
Niguldipine
-
Pardoprunox
-
Pelanserin
-
Perlapine
-
Phendioxan
-
Phenoxybenzamine
-
Phentolamine
-
Phenylpiperazine
antidepressants (e.g.,
hydroxynefazodone,
nefazodone,
trazodone,
triazoledione)
-
Piperoxan
-
Prazosin
-
Quinazosin
-
Quinidine
-
Silodosin
-
Spegatrine
-
Spiperone
-
Talipexole
-
Tamsulosin
-
Terazosin
-
Tiodazosin
-
Tolazoline
-
Tetracyclic antidepressants (e.g.,
amoxapine,
maprotiline,
mianserin)
-
Tricyclic antidepressants (e.g.,
amitriptyline,
clomipramine,
doxepin,
imipramine,
trimipramine)
-
Trimazosin
-
Typical antipsychotics (e.g.,
chlorpromazine,
fluphenazine,
loxapine,
thioridazine)
-
Urapidil
-
WB-4101
-
Zolertine
|
---|
|
---|
α2 | Agonists | |
---|
Antagonists |
-
1-PP
-
Adimolol
-
Amesergide
-
Aptazapine
-
Atipamezole
-
Atypical antipsychotics (e.g.,
asenapine,
brexpiprazole,
clozapine,
lurasidone,
olanzapine,
paliperidone,
quetiapine,
risperidone,
zotepine)
-
Azapirones (e.g.,
buspirone,
gepirone,
ipsapirone,
tandospirone)
-
BRL-44408
-
Buflomedil
-
Cirazoline
-
Efaroxan
-
Esmirtazapine
-
Fenmetozole
-
Fluparoxan
-
Idazoxan
-
Ketanserin
-
Lisuride
-
mCPP
-
Mianserin
-
Mirtazapine
-
NAN-190
-
Pardoprunox
-
Phentolamine
-
Phenoxybenzamine
-
Piperoxan
-
Piribedil
-
Rauwolscine
-
Rotigotine
-
Setiptiline
-
Spegatrine
-
Spiroxatrine
-
Sunepitron
-
Terguride
-
Tolazoline
-
Typical antipsychotics (e.g.,
chlorpromazine,
fluphenazine,
loxapine,
thioridazine)
-
Yohimbine
|
---|
|
---|
β | |
---|
|